Sibylle Loibl

36PUBLICATIONS
294CO-AUTHORS
Molecular targetsPalliative careCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (36)

|May 19, 2026
Exploratory Analysis of PTEN Deficiency by Immunohistochemistry from the Phase III CAPItello-291 Trial.

|Apr 29, 2026
Challenges and strategies for delivering effective breast cancer care in conflict zones.

|Apr 20, 2026
Durvalumab in Combination With Neoadjuvant Chemotherapy in Early Triple-Negative Breast Cancer: Long-Term Analysis From the GeparNuevo Trial.

|Oct 02, 2025
Supplementation of Tamoxifen with Low-Dose Endoxifen in Patients with Breast Cancer with Impaired Tamoxifen Metabolism (TAMENDOX): A Randomized Controlled Phase I/II Trial.

Thomas E Mürdter, Werner Schroth, Matthew P Goetz

|Sep 02, 2025
Reply to: Germline and Somatic BRCA1/2 Mutations in Breast Cancer Treatment Strategies.

Eric Hahnen, Jan Hauke, Karen Gelmon

|Jun 25, 2025
Q-TWiST Analysis to Assess Benefit-Risk of Sacituzumab Govitecan in Previously Treated Patients With Metastatic Triple-Negative Breast Cancer.

Aditya Bardia, Hope S Rugo, Mina S Sedrak

Pageof 6

Frequent Collaborators

20 joint publications

Carsten Denkert

14 joint publications

Michael Untch

13 joint publications

Valentina Nekljudova

12 joint publications

Peter Fasching